Correlation Between SNDL and Acumen Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both SNDL and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SNDL and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SNDL Inc and Acumen Pharmaceuticals, you can compare the effects of market volatilities on SNDL and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SNDL with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SNDL and Acumen Pharmaceuticals.
Diversification Opportunities for SNDL and Acumen Pharmaceuticals
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between SNDL and Acumen is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding SNDL Inc and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and SNDL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SNDL Inc are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of SNDL i.e., SNDL and Acumen Pharmaceuticals go up and down completely randomly.
Pair Corralation between SNDL and Acumen Pharmaceuticals
Given the investment horizon of 90 days SNDL Inc is expected to generate 0.92 times more return on investment than Acumen Pharmaceuticals. However, SNDL Inc is 1.09 times less risky than Acumen Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 134.00 in SNDL Inc on November 3, 2024 and sell it today you would earn a total of 40.00 from holding SNDL Inc or generate 29.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
SNDL Inc vs. Acumen Pharmaceuticals
Performance |
| Timeline |
| SNDL Inc |
| Acumen Pharmaceuticals |
SNDL and Acumen Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SNDL and Acumen Pharmaceuticals
The main advantage of trading using opposite SNDL and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SNDL position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.The idea behind SNDL Inc and Acumen Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |